{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:04:07Z","timestamp":1791489847263,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-025-00524-9","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T02:51:38Z","timestamp":1751943098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Minimal important differences of measurement instruments used in rheumatoid arthritis: a scoping review"],"prefix":"10.1186","volume":"9","author":[{"given":"Sally","family":"Yaacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas El","family":"Zouhbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michella Abi","family":"Zeid Daou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Nahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Mokbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal","family":"Hneiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Fraenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"524_CR1","doi-asserted-by":"crossref","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204-22.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"issue":"3 Suppl 59","key":"524_CR2","first-page":"S32","volume":"28","author":"V Strand","year":"2010","unstructured":"Strand V, Khanna D. The impact of rheumatoid arthritis and treatment on patients\u2019 lives. Clin Exp Rheumatol. 2010;28(3 Suppl 59):S32\u201340.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"524_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2217\/ijr.11.62","volume":"6","author":"M Margaretten","year":"2011","unstructured":"Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol. 2011;6(6):617\u201323.","journal-title":"Int J Clin Rheumatol"},{"issue":"13 Suppl","key":"524_CR4","first-page":"S295","volume":"18","author":"A Gibofsky","year":"2012","unstructured":"Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. 2012;18(13 Suppl):S295\u2013302.","journal-title":"Am J Manag Care"},{"key":"524_CR5","first-page":"86","volume":"41","author":"M Boers","year":"1994","unstructured":"Boers M, Tugwell P, Felson DT, van Riel PL, Kirwan JR, Edmonds JP, et al. World health organization and international league of associations for rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Supplement. 1994;41:86\u20139.","journal-title":"J Rheumatol Supplement"},{"issue":"2","key":"524_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1586\/erp.11.9","volume":"11","author":"MT King","year":"2011","unstructured":"King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev PharmacoEcon Outcomes Res. 2011;11(2):171\u201384.","journal-title":"Expert Rev PharmacoEcon Outcomes Res"},{"key":"524_CR7","doi-asserted-by":"crossref","unstructured":"Johnston BC, Ebrahim S, Carrasco-Labra A, Furukawa TA. Minimally important difference estimates and methods: a protocol. 2015;5(10):e007953.","DOI":"10.1136\/bmjopen-2015-007953"},{"issue":"4","key":"524_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407\u201315.","journal-title":"Control Clin Trials"},{"issue":"5","key":"524_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","volume":"7","author":"AG Copay","year":"2007","unstructured":"Copay AG, Subach BR, Glassman SD, Polly DW Jr., Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine Journal: Official J North Am Spine Soc. 2007;7(5):541\u20136.","journal-title":"Spine Journal: Official J North Am Spine Soc"},{"issue":"2","key":"524_CR10","first-page":"406","volume":"28","author":"G Wells","year":"2001","unstructured":"Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, et al. Minimal clinically important differences: review of methods. J Rhuematol. 2001;28(2):406\u201312.","journal-title":"J Rhuematol"},{"key":"524_CR11","doi-asserted-by":"crossref","unstructured":"Copay AG, Eyberg B. Minimum clinically important difference: current trends in the orthopaedic literature, part II: lower extremity: A systematic review. 2018;6(9):e2.","DOI":"10.2106\/JBJS.RVW.17.00160"},{"key":"524_CR12","unstructured":"Fraenkel L, Bathon JM, England BR. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. 2021;73(7):1108\u201323."},{"key":"524_CR13","doi-asserted-by":"crossref","unstructured":"Yaacoub S, Khamis AM. Using parallel streams of evidence to inform guideline development: the case of the 2021 American college of rheumatology management of rheumatoid arthritis guideline. 2021;3(9):629\u201335.","DOI":"10.1002\/acr2.11300"},{"issue":"7","key":"524_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"524_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jclinepi.2020.11.024","volume":"133","author":"A Carrasco-Labra","year":"2021","unstructured":"Carrasco-Labra A, Devji T, Qasim A, Phillips MR, Wang Y, Johnston BC, et al. Minimal important difference estimates for patient-reported outcomes: A systematic survey. J Clin Epidemiol. 2021;133:61\u201371.","journal-title":"J Clin Epidemiol"},{"key":"524_CR16","first-page":"m1714","volume":"369","author":"T Devji","year":"2020","unstructured":"Devji T, Carrasco-Labra A, Qasim A, Phillips M, Johnston BC, Devasenapathy N, et al. Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study. BMJ (Clinical Res ed). 2020;369:m1714.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"1","key":"524_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/acr.20346","volume":"63","author":"CS Batcho","year":"2011","unstructured":"Batcho CS, Durez P, Thonnard JL. Responsiveness of the ABILHAND questionnaire in measuring changes in rheumatoid arthritis patients. Arthritis Care Res. 2011;63(1):135\u201341.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"524_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/art.10190","volume":"46","author":"K Bruynesteyn","year":"2002","unstructured":"Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, et al. Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp\/van der Heijde and Larsen\/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum. 2002;46(4):913\u201320.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"524_CR19","first-page":"811","volume":"32","author":"D Cella","year":"2005","unstructured":"Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rhuematol. 2005;32(5):811\u20139.","journal-title":"J Rhuematol"},{"key":"524_CR20","doi-asserted-by":"crossref","unstructured":"Chernoff D, Scott Eastman P, Hwang CC, Flake DD 2nd, Wang X, Kivitz A, et al. Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores. Clin Rheumatol. 2019;38(2):437\u201345.","DOI":"10.1007\/s10067-018-4276-y"},{"issue":"6","key":"524_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/art.22090","volume":"55","author":"CF Chiou","year":"2006","unstructured":"Chiou CF, Sherbourne CD, Cornelio I, Lubeck DP, Paulus HE, Dylan M, et al. Development and validation of the revised Cedars-Sinai health-related quality of life for rheumatoid arthritis instrument. Arthritis Rheum. 2006;55(6):856\u201363.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"524_CR22","first-page":"256","volume":"33","author":"CF Chiou","year":"2006","unstructured":"Chiou CF, Sherbourne CD, Cornelio I, Lubeck DP, Paulus HE, Dylan M, et al. Revalidation of the original Cedars-Sinai health-related quality of life in rheumatoid arthritis questionnaire. J Rhuematol. 2006;33(2):256\u201362.","journal-title":"J Rhuematol"},{"issue":"10","key":"524_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/acr.22606","volume":"67","author":"JR Curtis","year":"2015","unstructured":"Curtis JR, Yang S, Chen L, Pope JE, Keystone EC, Haraoui B, et al. Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients. Arthritis Care Res. 2015;67(10):1345\u201353.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"524_CR24","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/ar3859","volume":"14","author":"M Dougados","year":"2012","unstructured":"Dougados M, Brault Y, Logeart I, van der Heijde D, Gossec L, Kvien T. Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the rheumatoid arthritis impact of disease (RAID). Arthritis Res Therapy. 2012;14(3):R129.","journal-title":"Arthritis Res therapy"},{"issue":"1","key":"524_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12955-016-0584-6","volume":"15","author":"M Dritsaki","year":"2017","unstructured":"Dritsaki M, Petrou S, Williams M, Lamb SE. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand. Health Qual Life Outcomes. 2017;15(1):20.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"524_CR26","doi-asserted-by":"publisher","first-page":"e0161727","DOI":"10.1371\/journal.pone.0161727","volume":"11","author":"I Gonz\u00e1lez-\u00c1lvaro","year":"2016","unstructured":"Gonz\u00e1lez-\u00c1lvaro I, Castrej\u00f3n I, Ortiz AM, Toledano E, Casta\u00f1eda S, Garc\u00eda-Vadillo A, et al. Cut-offs and response criteria for the Hospital Universitario La Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis. PLoS ONE. 2016;11(9):e0161727.","journal-title":"PLoS ONE"},{"issue":"1","key":"524_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/annrheumdis-2013-204053","volume":"74","author":"RD Hays","year":"2015","unstructured":"Hays RD, Spritzer KL, Fries JF, Krishnan E. Responsiveness and minimally important difference for the patient-reported outcomes measurement information system (PROMIS) 20-item physical functioning short form in a prospective observational study of rheumatoid arthritis. Ann Rheum Dis. 2015;74(1):104\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"524_CR28","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3899\/jrheum.080375","volume":"35","author":"D Khanna","year":"2008","unstructured":"Khanna D, Pope JE, Khanna PP, Maloney M, Samedi N, Norrie D, et al. The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice. J Rhuematol. 2008;35(12):2339\u201343.","journal-title":"J Rhuematol"},{"issue":"7","key":"524_CR29","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M","volume":"43","author":"M Kosinski","year":"2000","unstructured":"Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE, Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum. 2000;43(7):1478\u201387.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"524_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3899\/jrheum.090449","volume":"37","author":"MK Kvamme","year":"2010","unstructured":"Kvamme MK, Kristiansen IS, Lie E, Kvien TK. Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rhuematol. 2010;37(1):26\u201331.","journal-title":"J Rhuematol"},{"key":"524_CR31","doi-asserted-by":"crossref","unstructured":"Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med (1982). 2005;60(7):1571\u201382.","DOI":"10.1016\/j.socscimed.2004.08.034"},{"issue":"2","key":"524_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3899\/jrheum.080479","volume":"36","author":"JE Pope","year":"2009","unstructured":"Pope JE, Khanna D, Norrie D, Ouimet JM. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials. J Rhuematol. 2009;36(2):254\u20139.","journal-title":"J Rhuematol"},{"issue":"7","key":"524_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jclinepi.2007.08.016","volume":"61","author":"J Pouchot","year":"2008","unstructured":"Pouchot J, Kherani RB, Brant R, Lacaille D, Lehman AJ, Ensworth S, et al. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol. 2008;61(7):705\u201313.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"524_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jhsa.2008.11.001","volume":"34","author":"MJ Shauver","year":"2009","unstructured":"Shauver MJ, Chung KC. The minimal clinically important difference of the Michigan hand outcomes questionnaire. J Hand Surg. 2009;34(3):509\u201314.","journal-title":"J Hand Surg"},{"issue":"3","key":"524_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/14397595.2016.1213490","volume":"27","author":"K Shidara","year":"2017","unstructured":"Shidara K, Nakajima A, Inoue E, Hoshi D, Sugimoto N, Seto Y, et al. The minimally important difference for the Japanese version of the health assessment questionnaire in patients with rheumatoid arthritis in daily practice. Mod Rheumatol. 2017;27(3):430\u20134.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"524_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3899\/jrheum.180153","volume":"46","author":"MM Ward","year":"2019","unstructured":"Ward MM, Castrejon I, Bergman MJ, Alba MI, Guthrie LC, Pincus T. Minimal clinically important improvement of routine assessment of patient index data 3 in rheumatoid arthritis. J Rhuematol. 2019;46(1):27\u201330.","journal-title":"J Rhuematol"},{"issue":"6","key":"524_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jclinepi.2015.01.028","volume":"68","author":"MM Ward","year":"2015","unstructured":"Ward MM, Guthrie LC, Alba M. Domain-specific transition questions demonstrated higher validity than global transition questions as anchors for clinically important improvement. J Clin Epidemiol. 2015;68(6):655\u201361.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"524_CR38","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/acr.22392","volume":"66","author":"MM Ward","year":"2014","unstructured":"Ward MM, Guthrie LC, Alba MI. Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness. Arthritis Care Res. 2014;66(12):1783\u20139.","journal-title":"Arthritis Care Res"},{"issue":"9","key":"524_CR39","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/annrheumdis-2013-205079","volume":"74","author":"MM Ward","year":"2015","unstructured":"Ward MM, Guthrie LC, Alba MI. Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials. Ann Rheum Dis. 2015;74(9):1691\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"524_CR40","first-page":"280","volume":"34","author":"G Wells","year":"2007","unstructured":"Wells G, Li T, Maxwell L, MacLean R, Tugwell P. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis. J Rhuematol. 2007;34(2):280\u20139.","journal-title":"J Rhuematol"},{"issue":"3","key":"524_CR41","first-page":"557","volume":"20","author":"GA Wells","year":"1993","unstructured":"Wells GA, Tugwell P, Kraag GR, Baker PR, Groh J, Redelmeier DA. Minimum important difference between patients with rheumatoid arthritis: the patient\u2019s perspective. J Rhuematol. 1993;20(3):557\u201360.","journal-title":"J Rhuematol"},{"issue":"3","key":"524_CR42","first-page":"501","volume":"33","author":"PM Welsing","year":"2006","unstructured":"Welsing PM, Borm GF, van Riel P. Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective. J Rhuematol. 2006;33(3):501\u20137.","journal-title":"J Rhuematol"},{"issue":"8","key":"524_CR43","first-page":"1674","volume":"34","author":"F Wolfe","year":"2007","unstructured":"Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rhuematol. 2007;34(8):1674\u201383.","journal-title":"J Rhuematol"},{"key":"524_CR44","doi-asserted-by":"crossref","unstructured":"Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Gnann H, Greger G, et al. Use of a critical difference statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis. BMC Rheumatol. 2019;3:51.","DOI":"10.1186\/s41927-019-0095-2"},{"issue":"1","key":"524_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03009742.2019.1637932","volume":"49","author":"LM \u00d8rnbjerg","year":"2020","unstructured":"\u00d8rnbjerg LM, Christensen KB, Tennant A, Hetland ML. Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias. Scand J Rheumatol. 2020;49(1):1\u20137.","journal-title":"Scand J Rheumatol"},{"key":"524_CR46","doi-asserted-by":"crossref","unstructured":"Baker JF, Katz P. Defining minimum clinically important changes for the patient activity scale II. Arthritis Care Res. 2021;73(10):1456\u201360.","DOI":"10.1002\/acr.24335"},{"key":"524_CR47","doi-asserted-by":"crossref","unstructured":"Hoque A, Gallagher K, McEntegart A, Porter D, Steultjens M, Woodburn J, et al. Measuring inflammatory foot disease in rheumatoid arthritis: development and validation of the rheumatoid arthritis foot disease activity index-5. Arthritis Care Res. 2021;73(9):1290\u20139.","DOI":"10.1002\/acr.24259"},{"key":"524_CR48","doi-asserted-by":"crossref","unstructured":"Katz P, Kannowski CL, Sun L, Michaud K. Estimation of minimally important differences and patient acceptable symptom state scores for the patient-reported outcomes measurement information system pain interference short form in rheumatoid arthritis. ACR Open Rheumatol. 2020;2(6):320\u20139.","DOI":"10.1002\/acr2.11141"},{"key":"524_CR49","doi-asserted-by":"crossref","unstructured":"Greenwood MC, Doyle DV, Ensor M. Does the stanford health assessment questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis? Ann Rheumatic Dis. 2001;60(4):344\u20138.","DOI":"10.1136\/ard.60.4.344"},{"issue":"5","key":"524_CR50","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11136-022-03227-7","volume":"32","author":"SJ Bartlett","year":"2023","unstructured":"Bartlett SJ, Bykerk VP, Schieir O, Valois MF, Pope JE, Boire G, et al. From where I stand: using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ). Qual Life Res. 2023;32(5):1307\u201318.","journal-title":"Qual Life Res"},{"issue":"1","key":"524_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41687-024-00685-0","volume":"8","author":"R Rendas-Baum","year":"2024","unstructured":"Rendas-Baum R, Lin X, Kosinski M, Bjorner JB, Bracher MG, Chen WH. Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritis. J Patient-Reported Outcomes. 2024;8(1):9.","journal-title":"J patient-reported outcomes"},{"key":"524_CR52","doi-asserted-by":"crossref","unstructured":"McCann AC, Phillips KM, Trope M, Caradonna DS, Gray ST, Sedaghat AR. Characterising the potential for recall bias in anchor-based MCID calculation of patient-reported outcome measures for chronic rhinosinusitis. 2020;45(5):768\u201374.","DOI":"10.1111\/coa.13589"},{"issue":"4","key":"524_CR53","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/0194599819852604","volume":"161","author":"Sedaghat","year":"2019","unstructured":"Sedaghat AR. Understanding the minimal clinically important difference (MCID) of Patient-Reported outcome measures. Otolaryngology\u2013head Neck Surgery: Official J Am Acad Otolaryngology-Head Neck Surg. 2019;161(4):551\u201360.","journal-title":"Otolaryngology\u2013head Neck Surgery: Official J Am Acad Otolaryngology-Head Neck Surg"},{"key":"524_CR54","doi-asserted-by":"crossref","unstructured":"Franceschini M, Boffa A. The minimal clinically important difference changes greatly based on the different calculation methods. 2023;51(4):1067\u201373.","DOI":"10.1177\/03635465231152484"},{"issue":"1","key":"524_CR55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12955-020-01344-w","volume":"18","author":"Y Mouelhi","year":"2020","unstructured":"Mouelhi Y, Jouve E, Castelli C, Gentile S. How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods. Health Qual Life Outcomes. 2020;18(1):136.","journal-title":"Health Qual Life Outcomes"},{"key":"524_CR56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jclinepi.2016.11.016","volume":"82","author":"F Angst","year":"2017","unstructured":"Angst F, Aeschlimann A, Angst J. The minimal clinically important difference Raised the significance of outcome effects above the statistical level, with methodological implications for future studies. J Clin Epidemiol. 2017;82:128\u201336.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"524_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","volume":"47","author":"EF Juniper","year":"1994","unstructured":"Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994;47(1):81\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"524_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1179\/2042618612Y.0000000001","volume":"20","author":"A Wright","year":"2012","unstructured":"Wright A, Hannon J, Hegedus EJ, Kavchak AE. Clinimetrics corner: a closer look at the minimal clinically important difference (MCID). J Man Manip Ther. 2012;20(3):160\u20136.","journal-title":"J Man Manip Ther"},{"issue":"5","key":"524_CR59","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jclinepi.2009.08.010","volume":"63","author":"CB Terwee","year":"2010","unstructured":"Terwee CB, Roorda LD, Dekker J, Bierma-Zeinstra SM, Peat G, Jordan KP, et al. Mind the MIC: large variation among populations and methods. J Clin Epidemiol. 2010;63(5):524\u201334.","journal-title":"J Clin Epidemiol"},{"key":"524_CR60","doi-asserted-by":"crossref","unstructured":"Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol. 2002;14(2).","DOI":"10.1097\/00002281-200203000-00006"},{"key":"524_CR61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","volume":"150","author":"L Zeng","year":"2022","unstructured":"Zeng L, Brignardello-Petersen R, Hultcrantz M, Mustafa RA, Murad MH, Iorio A, et al. GRADE guidance 34: update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol. 2022;150:216\u201324.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"524_CR62","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1745-6215-13-132","volume":"13","author":"PR Williamson","year":"2012","unstructured":"Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13(1):132.","journal-title":"Trials"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00524-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-025-00524-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00524-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:03:46Z","timestamp":1751947426000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-025-00524-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["524"],"URL":"https:\/\/doi.org\/10.1186\/s41927-025-00524-9","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}